CYP3A and Drug Interactions
Serious adverse interactions between drugs continue to be reported. Many of these are due to inhibition or induction of cytochrome P450 (CYP) enzymes, particularly CYP3A4. CYP3A is thought to be involved in the metabolism of more than 50 percent of currently prescribed drugs.2 CYP3A4, which is more abundantly expressed than CYP3A5, accounts for most CYP3A activity in vivo....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: CYP3A and Drug Interactions
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1212
Article Code: 1212b
Date: July 4, 2005
Volume: 47
Pages: 54-55
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1212
Article Code: 1212b
Date: July 4, 2005
Volume: 47
Pages: 54-55
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)